Journals / Journal of Urological Surgery / 2019 / Cilt: 6 - Sayı: 4

Current Status of Urological Surgery Clinical Trials in the Middle East and Its Analysis in Comparison to Global

Orta Doğu’da Yürütülen Ürolojik Cerrahi Klinik Çalışmaların Bugünki Durumu ve Globale Kıyasla Analizi

Pages
266–272
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Fewcountries use the advantages of industry resources for conducting urological surgery CTs.Conclusion: The ME should be considered as a fertile land for adopting urological surgery CTs due to high population despite low ongoing studies.The lack of industry support in the ME is another problem, which may improve via rendering the ME more attractive for sponsors by adopting newregulatory guidelines for some of the countries

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To analyze the rates and types of ongoing urological surgery clinical trials (CTs) in the Middle East (ME) and worldwide.Materials and Methods: The number of urological surgery CTs was identified via the ClinicalTrials.gov database.
📊
Key Findings & Data:Studies were further analyzedusing different filters present in ClinicalTrials.gov.Results: Vast majority of urological surgery CTs are progressing in North America and Europe with 71.53%.
💡
Conclusion & Impact:Fewcountries use the advantages of industry resources for conducting urological surgery CTs.Conclusion: The ME should be considered as a fertile land for adopting urological surgery CTs due to high population despite low ongoing studies.The lack of industry support in the ME is another problem, which may improve via rendering the ME more attractive for sponsors by adopting newregulatory guidelines for some of the countries
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To analyze the rates and types of ongoing urological surgery clinical trials (CTs) in the Middle East (ME) and worldwide.Materials and Methods: The number of urological surgery CTs was identified via the ClinicalTrials.gov database. Studies were further analyzedusing different filters present in ClinicalTrials.gov.Results: Vast majority of urological surgery CTs are progressing in North America and Europe with 71.53%. The ME accounts for only 6.19%. In theME, only Turkiye hosts studies of pediatric urological surgery. Additionally, the vast majority of adult studies were also belongs to Turkiye with 64%.Further, the large portion of conducted CTs in the ME is phase 3 studies and studies with no phase indicated. Similarly, all urological surgery CTsconducted in Turkiye are in later phases or with no phase indicated. Moreover, industry resources are not directed upon these studies in the ME. Fewcountries use the advantages of industry resources for conducting urological surgery CTs.Conclusion: The ME should be considered as a fertile land for adopting urological surgery CTs due to high population despite low ongoing studies.The lack of industry support in the ME is another problem, which may improve via rendering the ME more attractive for sponsors by adopting newregulatory guidelines for some of the countries

Özet

Amaç: Ürolojik cerrahi klinik çalışmaların (CT) tipleri ve sayıları açısından Dünya’daki ve Orta Doğu’daki (OD) dağılımlarını incelemektir. Gereç ve Yöntem: Bu CT’lerin dağılımları ClinicalTrials.gov sitesi kullanılarak analiz edildi. Ortaya çıkan bilgiler sitede bulunan filtreleme seçenekleri kullanılarak daha detaylı bir şekilde araştırıldı. Bulgular: Ürolojik cerrahi CT’lerin %71,53’ü Kuzey Amerika ve Avrupa’da görülürken, OD Bölgesi bu çalışmaların sadece %6,19’unu oluşturmaktadır. Buna ek olarak, OD’deki pediyatrik çalışmaların hepsinin Türkiye’ye ait olduğu ortaya çıkmıştır. Ayrıca, Türkiye’de yürütülen ürolojik cerrahi CT’ler, OD’de yürütülen çalışmaların %64’ünü oluşturmaktadır. Başka bir konu ise, OD’de yürütülen CT’lerin büyük bir çoğunluğunu faz 3 çalışmalarının ve fazı belirtilmeyen çalışmaların oluşturmasıdır. Buna benzer şekilde, Türkiye’deki çalışmaların hepsi geç fazlara ait veya fazı belirtilmeyen çalışmalardır. OD Bölgesi’nde endüstri sermayesi ile yürütülen çalışmaların sayısı birkaç ülke dışında yok denecek kadar azdır. Sonuç: OD Bölgesi ürolojik cerrahi CT’leri yürütmek açısından verimli bir bölge olarak düşünülebilir. Bu bölgedeki hızla artan nüfus ve bununla doğru orantılı olarak ürolojik hastalıklardaki yaygınlık, yürütülen çalışmaların sayısı ile uyumululuk göstermemektedir. Az sayıdaki birkaç ülke hariç bu bölgede endüstri sermayesinin klinik çalışmalar lehine kullanılmaması da başka bir problemdir. Bu sorun OD Bölgesi’ni sponsorlar açısından daha cazip kılacak standartlar benimsenerek düzeltilebilir.

🔖

Cite This Article

Narter, F., Özdener, F., Sursal, A. (2022). Current Status of Urological Surgery Clinical Trials in the Middle East and Its Analysis in Comparison to Global. Journal of Urological Surgery, Cilt: 6 - Sayı: 4, 266–272. https://ajindex.com/articles/652661

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Alelign T, Petros B. Kidney Stone Disease: An Update on Current Concepts. Adv Urol 2018
  2. 3068365. 2. Y. S. Alghamdi S, M. A. Alamri A, A. M. Alzahrani R. Awareness about Symptoms and Role of Diet in Renal Stones among General Population of Albaha City. The Egyptian Journal of Hospital Medicine 2018
  3. Abrams P, Wein A. Recent advances: urology. BMJ 2000
  4. Murphy D, Challacombe B, Khan MS, Dasgupta P. Robotic technology in urology. Postgrad Med J 2006
  5. Romero V, Akpinar H, G Assimos D. Kidney Stones: A Global Picture of Prevalence, Incidence, and Associated Risk Factors. Rev Urol 2010
  6. e86- 96. 6. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003
  7. Scales CD, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. Eur Urol 2012
  8. Robertson WG. Stone formation in the Middle Eastern Gulf States: A review. Arab J Urol 2012
  9. Shields-Cutler RR, Crowley JR, Hung CS, Stapleton AE, Aldrich CC, Marschall J, Henderson JP. Human Urinary Composition Controls Antibacterial Activity of Siderocalin. J Biol Chem 2015
  10. 15949-15960. 10. Mathers CD, Lopez AD, Murray CJL. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Washington (DC): World BankThe International Bank for Reconstruction and Development/The World Bank Group
  11. Dirks JH, Levin NW. Dialysis rationing in South Africa: A global message. Kidney Int 2006
  12. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004
  13. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025: prevalence, numerical estimates, and projections. Diabetes Care 1998
  14. Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, Soto-Vega E. A comprehensive review of urologic complications in patients with diabetes. Springerplus 2014
  15. Ozdener F, Kirbiyik F, Dogan AE. Analysis of nutrition clinical studies involving children in the Middle East and globally. Future Sci OA 2018
  16. National Library of Medicine. ClinicalTrials.gov 2019, February 27. Available from: https://clinicaltrials.gov/ct2/home. 17. Huser V, Cimino JJ. Linking ClinicalTrials.gov and PubMed to track results